CSIMarket
 
Dr Reddy s Laboratories Limited  (NYSE: RDY)
 
Price: $11.7100 $-0.17 -1.431%
Day's High: $11.84000015258789 Week Perf: -2.66 %
Day's Low: $ 11.67 30 Day Perf: -5.94 %
Volume (M): 2,579,924 52 Wk High: $ 15.67
Volume (M$): $ 0 52 Wk Avg: $13.57
Open: $11.86 52 Wk Low: $10.27



 Market Capitalization (Millions $) 9,748
 Shares Outstanding (Millions) 832
 Employees 22,000
 Revenues (TTM) (Millions $) 3,580
 Net Income (TTM) (Millions $) 452
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 249

Business Description


Dr. Reddy's Laboratories is one of the leading global pharmaceutical companies, headquartered in Hyderabad, India. The company was founded in 1984 and has since grown to become a global player in the pharmaceutical industry, with a presence in over 100 countries.

The company's primary focus is on developing and manufacturing generic drugs, biosimilars, and innovative pharmaceutical products. Dr. Reddy's product portfolio includes a wide range of therapeutic areas such as cardiovascular, oncology, neurology, dermatology, and gastroenterology.

One of the key strengths of Dr. Reddy's is its R&D capabilities. The company has a dedicated team of scientists and researchers who work on developing new drugs, improving formulations, and enhancing the efficiency of existing products. Dr. Reddy's has invested significantly in building state-of-the-art R&D facilities and collaborations with leading academic institutions and research organizations.

In addition to generic and biosimilar drugs, Dr. Reddy's also has a strong presence in the consumer health business through its subsidiary, Dr. Reddy's Laboratories, Inc. The company has a portfolio of OTC products such as pain relievers, cough and cold remedies, and digestive health supplements.

Dr. Reddy's has a global presence with manufacturing facilities in multiple countries, including India, the US, Mexico, and Russia. The company's sales and marketing activities are also spread across different geographies, with a significant focus on the US and Europe.

In recent years, Dr. Reddy's has made significant strides in creating a more sustainable business model, with a focus on reducing its carbon footprint, conserving energy, and developing eco-friendly products. The company is also committed to giving back to society, with initiatives such as providing free healthcare to underprivileged communities and supporting education programs.

Overall, Dr. Reddy's Laboratories is a well-established, innovative, and socially responsible organization that is poised for continued growth in the global pharmaceutical industry.


   Company Address: 8-2-337 Hyderabad 500
   Company Phone Number: 66022564   Stock Exchange / Ticker: NYSE RDY


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -2.57%    
AMRX   -6.59%    
PFE   -4.74%    
PRGO   -6.21%    
TEVA   -3.04%    
VTRS   -4.15%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.72
Price to Sales (Expected) -
Price to Book 2.4
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.09
Working Capital Ratio 1.8
Leverage Ratio (MRQ) 0.52
Total Debt to Equity 0.06
Interest Coverage (TTM) -
Debt Coverage (TTM) 2.53

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) 4.3 $
Cash Flow (TTM) -
Cash 0.2 $
Book Value 4.87 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 162,727
Net Income per Employee (TTM) 20,545
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.58

Profitability Ratios Current
Gross Margin (MRQ) 52.77 %
Operating Margin (MRQ) 15.06 %
Net Margin (MRQ) 12.63 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 22.6 %

Management Effectiveness Current
Return On Assets (TTM) 7.32 %
Return On Investment (TTM) 10.3 %
Return On Equity (TTM) 11.15 %
Dividend Yield -
Pay out Ratio (TTM) -



Dr Reddy S Laboratories Limited's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.